サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363131

腸疾患検査の市場規模、シェア、動向分析レポート：疾患タイプ別、地域別、セグメント予測、2023年～2030年

Enteric Disease Testing Market Size, Share & Trends Analysis Report By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 90 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
腸疾患検査の市場規模、シェア、動向分析レポート：疾患タイプ別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月22日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腸疾患検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の腸疾患検査市場規模は、2023年から2030年にかけて2.7%のCAGRを記録し、2030年までに46億8,000万米ドルに達する見込みです。

コレラやその他の下痢性疾患などの病気を治療するための迅速な診断に対する需要の増加、不衛生な生活環境に伴う高齢化人口の増加、腸疾患に対する医療検査の適用拡大などが、予測期間にわたって市場を牽引すると見られています。

この成長はさらに、ヘルスケア支出の増加、政府の支援策、疾患有病率の増加にも起因しています。劣悪な衛生環境、衛生的な食品や水の供給が受けられず貧困ライン以下で生活する人口の増加といった経済的・環境的要因は、感染症の罹患率の上昇に起因しており、市場の成長を促進しています。

ビル・アンド・メリンダ・ゲート財団のデータベースによると、腸疾患は毎年約50万人の死亡原因となっており、今後さらに増加すると予測されています。死亡率が最も高いのは75歳以上で、次いで5歳以下の子供です。

WHOやユニセフのようなヘルスケア連邦機関が、致死率を効果的に管理するための戦略的イニシアチブをとっていることが、市場の成長を後押しすると予想されます。これらの機関は、啓発プログラムやヘルスケアキャンプを実施することで、こうした感染症の検査を広く普及させることに取り組んでいます。また、これらの感染症の蔓延を抑えるために、第三世界各国の現地機関に資金援助を行っています。

腸疾患検査市場レポートハイライト

  • 細菌性腸疾患検査市場は、最大の収益シェアを占め、2023年から2030年までの予測期間中、これらの感染症の発生が多いことから、最も速いCAGRで成長すると予測されています。Johns Hopkins Bloomberg School of Public Healthの調査によると、細菌感染による下痢で年間約400万～600万人が死亡しています。
  • 寄生虫性腸疾患検査市場は、CAGR 1.9%で大幅な成長が見込まれます。WHOは、ランブル鞭毛虫、クリプトスポリジウム、ヒストリチカなどの寄生虫によって年間2億人以上が感染していると推定しています。
  • 欧州は、高齢人口の増加、移民の増加、患者の意識レベルの向上と比較的高い医療費により、2022年に39.0%の最大収益シェアで市場を独占しました。
  • アジア太平洋地域は、2023年から2030年までの予測期間中、CAGR 4.0%の最速成長が見込まれています。日本、中国、インドなどの国々では、認知度を高め、より高い検査を推進するための政府の取り組みが、予測期間にわたって市場を牽引すると期待されています。
  • 業界各社は、新製品の発売や既存技術のアップグレードで常に市場を活性化しています。2015年1月、バイオメリカは米国特許商標庁に胃腸障害の検出に使用される検査に関する特許を申請しました。
  • 技術革新とは別に、多くの業界プレーヤーが互いの強みを生かすために協力し、より高い利益を得るために戦略的提携を結んでいます。例えば、2017年5月、Quest diagnosticsはPeaceHealthとの協業を発表し、価値の高いデザインとイノベーションを通じてサービスを強化しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腸疾患検査市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 腸疾患検査市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 腸疾患検査市場：疾患タイプの推定・動向分析

  • 腸疾患検査市場、重要なポイント
  • 腸疾患検査市場：動向と市場シェア分析、2022年および2030年
  • 細菌性腸疾患
  • ウイルス性腸疾患
  • 寄生虫性腸疾患

第5章 腸疾患検査市場：地域推定・動向分析

  • 地域別の展望
  • 地域別の腸疾患検査市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Abbott
    • BD
    • Biomerica
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Coris BioConcept
    • DiaSorin S.p.A.
    • Meridian Bioscience
    • Quest Diagnostics Incorporated
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 3 North America enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 5 Canada enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 6 Europe enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 7 Europe enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 UK enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 10 France enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 11 Italy enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 12 Spain enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 13 Sweden enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 14 Norway enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 15 Denmark enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 18 Japan enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 19 China enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 20 India enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 21 Australia enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Thailand enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 23 South Korea enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 24 Latin America enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 25 Latin America enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 27 Mexico enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 28 Argentina enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 33 UAE enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait enteric disease testing market, by disease type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Enteric disease testing: market outlook
  • Fig. 9 Enteric disease testing competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Enteric disease testing market driver impact
  • Fig. 15 Enteric disease testing market restraint impact
  • Fig. 16 Enteric disease testing market strategic initiatives analysis
  • Fig. 17 Enteric disease testing market: Disease type movement analysis
  • Fig. 18 Enteric disease testing market: Disease type outlook and key takeaways
  • Fig. 19 Bacterial enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Viral enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Rotavirus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Norovirus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Parasitic enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Enteric disease testing market: Regional movement analysis
  • Fig. 25 Enteric disease testing market: Regional outlook and key takeaways
  • Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-542-7

Enteric Disease Testing Market Growth & Trends:

The global enteric disease testing market size is expected to reach USD 4.68 billion by 2030, registering a CAGR of 2.7% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied by unhygienic living conditions, and growing application of medical testing for enteric diseases are expected to drive the market over the forecast period.

The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease prevalence rate. Economic and environmental factors such as poor sanitation and the rising population living below the poverty line with no access to hygienic food and water supply are attributed to the growing incidence rate of the infections and thus propel the market growth.

According to the database of Bill and Melinda Gate Foundation, enteric diseases were responsible for about 500,000 deaths each year and these are anticipated to increase further. The highest mortality rate was observed amongst people above 75 years of age followed by children under 5 years of age.

Strategic initiatives by healthcare federal bodies such as the WHO and UNICEF, to manage the disease fatality effectively are expected to assist market growth. These agencies are working towards promoting widespread testing of people for such infections by conducting awareness programmes and healthcare camps. They also fund local agencies in third world countries to limit the spread of these infections.

Enteric Disease Testing Market Report Highlights:

  • Bacterial enteric disease testing market segment dominated with the largest revenue share and is also expected to grow at the fastest CAGR during the forecast period from 2023 to 2030 due to a higher occurrence of these infections. According to research conducted by Johns Hopkins Bloomberg School of Public Health, around four to six million people die annually due to bacterial infection-induced diarrhea.
  • The parasitic enteric disease testing market is expected to register significant growth with CAGR of 1.9%. The WHO has estimated over 200 million people to be infected annually by parasites such as giardia lamblia, cryptosporidium, and E. histolytica.
  • Europe dominated the market with the largest revenue share of 39.0% in 2022, owing to rising geriatric population base, increasing number of immigrants, and rising patient awareness levels coupled with relatively higher healthcare expenditures in the region.
  • Asia Pacific is expected to grow at the fastest CAGR of 4.0% over the forecast period from 2023 to 2030. Government efforts in countries such as Japan, China, and India to increase awareness and promote higher testing are expected to drive the market over the forecast period.
  • Industry players are constantly fueling the market with new product launches or upgrading the existing technology. In January 2015, Biomerica filed a patent application with the U.S. Patent and Trademark Office for a test used in the detection of gastrointestinal disorder.
  • Apart from technology innovation, many industry players are collaborating to use each other's strengths and are formulating strategic alliances in order to incur higher profits. For instance, in May 2017, Quest diagnostics announced a collaboration with PeaceHealth to enhance the service through high-value design and innovation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Disease type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Enteric Disease Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Enteric Disease Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Enteric Disease Testing Market: Disease Type Estimates & Trend Analysis

  • 4.1. Enteric Disease Testing Market, Key Takeaways
  • 4.2. Enteric Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bacterial Enteric Disease
    • 4.3.1. Bacterial enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Viral Enteric Disease
    • 4.4.1. Viral enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Rotavirus
      • 4.4.2.1. Rotavirus market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Norovirus
      • 4.4.3.1. Norovirus market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Parasitic Enteric Disease
    • 4.5.1. Parasitic enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Enteric Disease Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Enteric Disease Testing Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Abbott
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. BD
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Biomerica
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. BIOMERIEUX
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Bio-Rad Laboratories, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Cepheid
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Coris BioConcept
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. DiaSorin S.p.A.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Meridian Bioscience
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Quest Diagnostics Incorporated
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives